1 / 20

Malignant external otitis Necrotizing external otitis

Malignant external otitis Necrotizing external otitis. Dr. WASEEM WATAD. Case 1. ( SH. Y ). 80 years old 3VD , PTCA , DM-type2 , HTN , BPH Ext. otitis with PO ABX and ear drops with improvement several months before admission

csharpton
Download Presentation

Malignant external otitis Necrotizing external otitis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Malignant external otitis Necrotizing external otitis Dr. WASEEM WATAD

  2. Case 1. ( SH. Y ) • 80 years old • 3VD , PTCA , DM-type2 , HTN , BPH • Ext. otitis with PO ABX and ear drops with improvement several months before admission • severe Rt. otalgia , facial pain Rt. , and Rt. parotid mass at admission 19/09/04 • Rt ear discharge • Weight loss

  3. Case 1. • CT scan (20/09/04): Rt parotid mass , infiltration of parapharyngeal fat , EAC , infratemporal fossa , Rt. lat. pterygoid and masseter .no bony erosion and no lymphadenopathy • MRI (19/10/04) :process infiltrating the Rt. ear,temporal bone , TMJ, sphenoid sinus , infratemporal fossa and skull base • Biopsy of EAC polyp, parotid FNA (28/10/04) – mixed inflammation • Positive culture for p. aeruginosa

  4. Case 1. • IV ABX treatment ( cephalosporine and quinolones ) with ear drops and toilette • Improvement in pain , ear discharge • There was no CN involvement

  5. Case 2. ( Va. D ) • 68 years old • DM-type 2 , HTN • Hyperlipidemia , s/p CVA • Rt. Nasopharyngeal mass – biopsy no malignancy (11/04) • Bil. Ext. otitis 09/04 ( several weeks before admittion ) prolong ABX treatment ( semi-synthetic penicillin , quinolone) and ear drops

  6. Case 2. • No improvement • Rt. Severe otalgia , ear discharge , persistent rt. ext. otitis , with granulation tissue • Elevated ESR , negative culture for p. aeruginosa • Start IV ceftazidime ( 5 weeks ) • Progression findings in serial CT/MRI

  7. Case 2. • CT scan ( 14/11/04 ) - infiltration of the rt. parapharyngeal space , rt. Mastoid and middle ear, infiltrating of infratemporal fossa • MRI ( 24/21/04 ) – large mass in rt. parapharyngeal space with involvement of rt. TMJ and deep lobe of rt. Parotis • CT (01/05) infiltrating in rt. TMJ

  8. Case 2. • De’bridment - (10/01/05) ,. (24/01/05), • Hx – inflammatory tissue • 2 weeks of AMIKACIN + MEROPENEM • Exacerbation of Rt. Otalgia , ear discharge and relapse of granulation tissue of EAC • Treatment failure ?? • Further therapy : • Broad spectrum of ABX – combination of cephalosporines and quinolone • Surgical treatment – mastoidectomy +/- tympanoplasty , ablation of granulating and necrotizing tissue, bone and cartilage sequestrations • HBO

  9. Parietal Frontal Temporal Sphenoid Z Maxilla Lat. Pterygoid Plate Pterygomaxillary Fissure Infratemporal Fossa

  10. MEO - criteria • Sade’ (1989) : • Severe EXT. otitis unresponsive to at least 10 days of conservative treatment • Increasing agonizing pain exacerbated at night • Granulation tissue in the base of EAC • Repeated isolation of pseudomonas • Levenson (1991) : • Refractory otitis ext. • Severe otalgia , worse at night • Purulent exudate , granulation tissue • Recovery of P. aeruginosa • DM , immune state compromise • Positive Tc-99 bone scan of temporal bone

  11. etiopathogenesis

  12. MEO - staging • Corey (1985) : • I - Infection of bone and soft tissue without cranial nerves lesions or intracranial lesions • II- cranial nerve paralysis • a- VII paralysis only • b- Multiple cranial nerves paralysis • III – meningitis , epidural empyema , subdural empyema or brain abscess

  13. NEO - diagnosis • Clinical findings • Laboratory tests • Culture • Ga-67, Tc-99 scans • HR-CT with contrast • Biopsy of granulation tissue

  14. mortality • 46% (1968) • 10% recent articles • High mortality in facial n. paralysis

  15. Management – cont. • HR-CT contrast evaluation • Ga-67 (every 4 weeks) follow up with treatment • Management underlying process ( DM / immunosuppressive) • Surgical de’bridment ,drinage – intracranial ext. , brain abscess • 6 weeks of ABX , repeat cultures , oral ABX after 2 weeks of cessation of symptoms

  16. Management – cont. • Deep biopsy of granulation tissue – underlying carcinoma

  17. Therapeutic problems • Main problem is : • Choice of the ABX • Duration of treatment

  18. Therapeutic problems • Duration of treatment • Standard indication ( 6-8 weeks ) • Identifying objective parameter of definitive recovery • Healing of skin EAC • ESR • Ga-67

  19. Therapeutic problems • Surgical treatment : • Complementary role • Mastoidectomy +/- tympanoplasty • Recommendation – biopsy , cleansing , ablation of necrotizing and granulation tissue and the bone , cartilage sequestrations

  20. Therapeutic problems • Hyperbaric oxygen therapy • Daily , 2.4-3 atm, 90 minutea , 30 courses • Indications : advanced stages , recurrent cases, refractory to ABX • Hypoxia impaired oxygen dependent bacterial killing by phagocytosis

More Related